These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38825303)

  • 21. Effects of L-type Ca2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome 3.
    Thomas G; Gurung IS; Killeen MJ; Hakim P; Goddard CA; Mahaut-Smith MP; Colledge WH; Grace AA; Huang CL
    J Physiol; 2007 Jan; 578(Pt 1):85-97. PubMed ID: 17110414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late onset left ventricular dysfunction and cardiomyopathy induced with ibrutinib.
    Gülsaran SK; Baysal M; Demirci U; Baş V; Kirkizlar HO; Umit E; Demir AM
    J Oncol Pharm Pract; 2020 Mar; 26(2):478-480. PubMed ID: 31142233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bruton's tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation.
    Sestier M; Hillis C; Fraser G; Leong D
    Curr Oncol Rep; 2021 Aug; 23(10):113. PubMed ID: 34342738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Bruton's tyrosine kinase inhibitor ibrutinib abrogates bispecific antibody-mediated T-cell cytotoxicity.
    Godwin CD; Bates OM; Garling EE; Beddoe ME; Laszlo GS; Walter RB
    Br J Haematol; 2020 Apr; 189(1):e9-e13. PubMed ID: 32017058
    [No Abstract]   [Full Text] [Related]  

  • 25. Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart.
    Hothi SS; Gurung IS; Heathcote JC; Zhang Y; Booth SW; Skepper JN; Grace AA; Huang CL
    Pflugers Arch; 2008 Nov; 457(2):253-70. PubMed ID: 18600344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiology and Arrhythmogenesis in the Human Right Ventricular Outflow Tract.
    Aras K; Gams A; Faye NR; Brennan J; Goldrick K; Li J; Zhong Y; Chiang CH; Smith EH; Poston MD; Chivers J; Hanna P; Mori S; Ajijola OA; Shivkumar K; Hoover DB; Viventi J; Rogers JA; Bernus O; Efimov IR
    Circ Arrhythm Electrophysiol; 2022 Mar; 15(3):e010630. PubMed ID: 35238622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrical and Structural Insights into Right Ventricular Outflow Tract Arrhythmogenesis.
    Lu YY; Chen YC; Lin YK; Chen SA; Chen YJ
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ibrutinib and Bruton's Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Focus on Atrial Fibrillation and Ventricular Tachyarrhythmias/Sudden Cardiac Death.
    Boriani G; Menna P; Morgagni R; Minotti G; Vitolo M
    Chemotherapy; 2023; 68(2):61-72. PubMed ID: 36366814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of effector B cells by ibrutinib in systemic sclerosis.
    Einhaus J; Pecher AC; Asteriti E; Schmid H; Secker KA; Duerr-Stoerzer S; Keppeler H; Klein R; Schneidawind C; Henes J; Schneidawind D
    Arthritis Res Ther; 2020 Mar; 22(1):66. PubMed ID: 32228672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of CaMKII depresses conduction preferentially in the right ventricular outflow tract and promotes ischemic ventricular fibrillation in the rabbit heart.
    Warren M; Sciuto KJ; Taylor TG; Garg V; Torres NS; Shibayama J; Spitzer KW; Zaitsev AV
    Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H752-H767. PubMed ID: 28130334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repolarization heterogeneity in the right ventricular outflow tract: correlation with ventricular arrhythmias in Brugada patients and in an in vitro canine Brugada model.
    Morita H; Zipes DP; Fukushima-Kusano K; Nagase S; Nakamura K; Morita ST; Ohe T; Wu J
    Heart Rhythm; 2008 May; 5(5):725-33. PubMed ID: 18452878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conduction in the right and left ventricle is differentially regulated by protein kinases and phosphatases: implications for arrhythmogenesis.
    Zaitsev AV; Torres NS; Cawley KM; Sabry AD; Warren JS; Warren M
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1507-H1527. PubMed ID: 30875259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of late sodium current by Ca
    Fu C; Hao J; Zeng M; Song Y; Jiang W; Zhang P; Luo A; Cao Z; Belardinelli L; Ma J
    Exp Physiol; 2017 Jul; 102(7):818-834. PubMed ID: 28436159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacology and PK/PD translation of the second-generation Bruton's tyrosine kinase inhibitor, zanubrutinib.
    Tam CS; Ou YC; Trotman J; Opat S
    Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1329-1344. PubMed ID: 34491123
    [No Abstract]   [Full Text] [Related]  

  • 35. Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib.
    Denzinger V; Busygina K; Jamasbi J; Pekrul I; Spannagl M; Weber C; Lorenz R; Siess W
    Thromb Haemost; 2019 Mar; 119(3):397-406. PubMed ID: 30685871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex and regional differences in rabbit right ventricular L-type calcium current levels and mathematical modelling of arrhythmia vulnerability.
    Kalik ZM; Mike JL; Slipski C; Wright M; Jalics JZ; Womble MD
    Exp Physiol; 2017 Jul; 102(7):804-817. PubMed ID: 28436171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.
    Woyach JA; Furman RR; Liu TM; Ozer HG; Zapatka M; Ruppert AS; Xue L; Li DH; Steggerda SM; Versele M; Dave SS; Zhang J; Yilmaz AS; Jaglowski SM; Blum KA; Lozanski A; Lozanski G; James DF; Barrientos JC; Lichter P; Stilgenbauer S; Buggy JJ; Chang BY; Johnson AJ; Byrd JC
    N Engl J Med; 2014 Jun; 370(24):2286-94. PubMed ID: 24869598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ibrutinib Suppresses Early Megakaryopoiesis but Enhances Proplatelet Formation.
    Huang J; Huang S; Ma Z; Lin X; Li X; Huang X; Wang J; Ye W; Li Y; He D; Yang M; Pan J; Ling Q; Li F; Mao S; Wang H; Wang Y; Jin J
    Thromb Haemost; 2021 Feb; 121(2):192-205. PubMed ID: 32961571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib.
    Dadashian EL; McAuley EM; Liu D; Shaffer AL; Young RM; Iyer JR; Kruhlak MJ; Staudt LM; Wiestner A; Herman SEM
    Cancer Res; 2019 Jan; 79(2):360-371. PubMed ID: 30498085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time resolved quantitative phospho-tyrosine analysis reveals Bruton's Tyrosine kinase mediated signaling downstream of the mutated granulocyte-colony stimulating factor receptors.
    Dwivedi P; Muench DE; Wagner M; Azam M; Grimes HL; Greis KD
    Leukemia; 2019 Jan; 33(1):75-87. PubMed ID: 29977015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.